Who Said That?
"It’s going to be hard to keep a lid on it. There’s going to be so much demand."
-- Dr. H. Thomas Temple, professor of orthopedics, vice chair of orthopedic surgery and director of the University of Miami Tissue Bank
A partnership between University of Miami researchers and a Georgia-based biomedical company this month made a new type of stem cell commercially available for bone regeneration and healing.
The marrow-isolated adult multi-lineage inducible cell, known as the MIAMI cell, is the result of 15 years of research by the University of Miami.
Since the stem cell was made commercially available, about 21 patients have been treated with a MIAMI cell infusion.
Read more at Miami Today.